VWF and thrombotic thrombocytopenic purpura: This may serve to specifically remove circulating, spontaneously elongated high molecular weight VWF multimers arising from conditions of pathologic shear stress (i.e. stenotic vessels) or ADAMTS‐13 deficiency (TTP), and may prevent the formation of microthrombi under these circumstances.